Breaking News

Financial Report: West

By Kristin Brooks | February 20, 2014

Revenues up 7% in the quarter

West

4Q Revenues: $342.7 million (+7%)

4Q Earnings: $23.6 million (+12%) 

FY Revenues: $1.4 billion (+8%)

FY Earnings: $112.3 (+39%)

Comments: Pharmaceutical Packaging Systems (PPS) sales in the quarter were $241.5 million, up 6%. Standard packaging component sales grew 5% and high-value products grew 4%, excluding currency effects. Pharmaceutical Delivery Systems (PDS) sales were $101.8 million in the quarter, up 8%. R&D costs increased 13% to $9.7 million in the quarter, primarily due to increasing investments in high-value products development.

blog comments powered by Disqus
  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.

  • Optimizing Collaboration Effectiveness in Alliance Partnerships

    Optimizing Collaboration Effectiveness in Alliance Partnerships

    Mary Jo Lamberti, Phil Birch, Ranjana Chakravarthy, Ken Getz, Tufts CSDD||January 28, 2016